{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2025-09-19", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "codes": [ { "uuid": "1cc91008-1f0d-4b60-8c28-24cbef2ac5ba", "code": "P50750", "type": "PRIMARY", "url": "http://www.uniprot.org/uniprot/P50750", "code_system": "UNIPROT", "references": [ "34bd5356-c463-4cf5-ad5b-fb172c65da39" ] }, { "uuid": "75a92c86-a7dd-4540-ace8-90f618245390", "code": "P50750", "type": "PRIMARY", "url": "https://pharos.nih.gov/idg/search?q=P50750", "code_system": "PHAROS", "references": [ "34bd5356-c463-4cf5-ad5b-fb172c65da39" ] }, { "uuid": "07ff5c32-1bd6-42f5-b0d3-641dc730099f", "code": "U3P2YH5TIJ", "type": "PRIMARY", "code_system": "FDA UNII" } ], "substance_class": "protein", "references": [ { "uuid": "0c5bc5bd-e3ea-4567-bd30-86e0cd5d3ee3", "citation": "Dey, Joyoti, et al. \"Voruciclib, a clinical stage oral CDK9 inhibitor, represses MCL-1 and sensitizes high-risk diffuse large B-cell lymphoma to BCL2 inhibition.\" Scientific reports 7.1 (2017): 18007.", "url": "https://www.nature.com/articles/s41598-017-18368-w", "doc_type": "JA", "public_domain": true }, { "uuid": "1fd8d813-4346-4869-ae03-be049cdc7cb6", "citation": "Sánchez-Martínez, Concepción, et al. \"Cyclin Dependent Kinase (CDK) inhibitors as anticancer drugs: Recent Advances (2015-2019).\" Bioorganic & medicinal chemistry letters (2019): 126637.", "url": "https://www.sciencedirect.com/science/article/pii/S0960894X19305827", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "4adbba03-0001-4945-b401-a47431a5eac8", "citation": "http://www.uniprot.org/uniprot/P50750", "url": "http://www.uniprot.org/uniprot/P50750", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE", "AUTO_SELECTED" ] }, { "uuid": "497f6f00-e9ba-4c4c-8611-1979f62a3d09", "citation": "UNIPROT", "doc_type": "UNIPROT", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "904119e2-29cf-4331-9d3d-568472cf103b", "citation": "uniprot.org/uniprot/P50750", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "34bd5356-c463-4cf5-ad5b-fb172c65da39", "citation": "SRS CODE IMPORT", "doc_type": "SRS", "public_domain": true, "document_date": 1493393918000, "tags": [ "NOMEN" ] }, { "uuid": "3de68a42-bfd6-4e7b-a63f-ba616da3d307", "citation": "Nemunaitis, J.J., Small, K.A., Kirschmeier, P. et al. A first-in-human, phase 1, dose-escalation study of dinaciclib, a novel cyclin-dependent kinase inhibitor, administered weekly in subjects with advanced malignancies. J Transl Med 11, 259 (2013). https://doi.org/10.1186/1479-5876-11-259", "url": "https://translational-medicine.biomedcentral.com/articles/10.1186/1479-5876-11-259#citeas", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "e601a253-ef8b-14f7-1f43-2e22bfc70c0e", "citation": "https://www.uniprot.org/uniprot/P50750", "url": "https://www.uniprot.org/uniprot/P50750", "doc_type": "UNIPROT", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "4b42a54e-8801-44d3-8e84-035d66a35bd9", "citation": "PUBCHEM", "doc_type": "PUBCHEM", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "16533120-65a6-419c-8ab0-6044065b5a86", "citation": "STN (SCIFINDER)", "doc_type": "STN (SCIFINDER)", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "382252de-f52f-4994-b573-46929b9fa515", "citation": "Sánchez-Martínez, Concepción, et al. \"Cyclin Dependent Kinase (CDK) inhibitors as anticancer drugs: Recent Advances (2015-2019).\" Bioorganic & medicinal chemistry letters (2019): 126637.", "url": "https://www.sciencedirect.com/science/article/pii/S0960894X19305827", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "c7020ace-c081-4c4c-b3ce-382b7a43b5d4", "citation": "Sánchez-Martínez, Concepción, et al. \"Cyclin Dependent Kinase (CDK) inhibitors as anticancer drugs: Recent Advances (2015-2019).\" Bioorganic & medicinal chemistry letters (2019): 126637.", "url": "https://www.sciencedirect.com/science/article/pii/S0960894X19305827", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "84fdca82-f3be-494c-94ab-c19b28d30bf0", "citation": "Yuan, Kai, et al. \"Selective inhibition of CDK4/6: A safe and effective strategy for developing anticancer drugs.\" Acta Pharmaceutica Sinica B 11.1 (2021): 30-54.", "url": "https://www.sciencedirect.com/science/article/pii/S2211383520305839", "doc_type": "JA", "public_domain": true }, { "uuid": "a853084b-5fbe-4c68-a22e-0e1cd50be6ed", "citation": "Łukasik, Paweł, et al. \"Inhibitors of cyclin-dependent kinases: Types and their mechanism of action.\" International Journal of Molecular Sciences 22.6 (2021): 2806.", "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001317/pdf/ijms-22-02806.pdf", "doc_type": "JA", "public_domain": true }, { "uuid": "1175a8ef-a7cf-4330-b51a-37b9b3e4f411", "citation": "Byth, Kate F., et al. \"AZD5438, a potent oral inhibitor of cyclin-dependent kinases 1, 2, and 9, leads to pharmacodynamic changes and potent antitumor effects in human tumor xenografts.\" Molecular cancer therapeutics 8.7 (2009): 1856-1866.", "url": "https://aacrjournals.org/mct/article/8/7/1856/93617/AZD5438-a-potent-oral-inhibitor-of-cyclin", "doc_type": "JA", "public_domain": true }, { "uuid": "52b5094d-4454-4af6-9021-d7a9f2f35ff6", "citation": "Wu, Tizhi, et al. \"Recent developments in the biology and medicinal chemistry of CDK9 inhibitors: an update.\" Journal of medicinal chemistry 63.22 (2020): 13228-13257.", "url": "https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c00744", "doc_type": "JA", "public_domain": true }, { "uuid": "86f3eda4-4ed3-493f-948b-44f0d51763e5", "citation": "Sánchez-Martínez, Concepción, et al. \"Cyclin Dependent Kinase (CDK) inhibitors as anticancer drugs: Recent Advances (2015-2019).\" Bioorganic & medicinal chemistry letters (2019): 126637.", "url": "https://www.sciencedirect.com/science/article/pii/S0960894X19305827", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "61c2588a-f47f-40b6-9956-5ff0ba0e75c9", "citation": "Wu, Tizhi, et al. \"Recent developments in the biology and medicinal chemistry of CDK9 inhibitors: an update.\" Journal of medicinal chemistry 63.22 (2020): 13228-13257.", "url": "https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c00744", "doc_type": "JA", "public_domain": true }, { "uuid": "5385ee69-f75a-4c9c-9537-baa9a6a64d6f", "citation": "Wu, Tizhi, et al. \"Recent developments in the biology and medicinal chemistry of CDK9 inhibitors: an update.\" Journal of medicinal chemistry 63.22 (2020): 13228-13257.", "url": "https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c00744", "doc_type": "JA", "public_domain": true }, { "uuid": "59f73705-5c4c-4b68-9b3c-bf0735c6a97e", "citation": "Sánchez-Martínez, Concepción, et al. \"Cyclin Dependent Kinase (CDK) inhibitors as anticancer drugs: Recent Advances (2015-2019).\" Bioorganic & medicinal chemistry letters (2019): 126637.", "url": "https://www.sciencedirect.com/science/article/pii/S0960894X19305827", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "af1237a0-1e18-481b-844f-833b0720e2e4", "citation": "Wu, Tizhi, et al. \"Recent developments in the biology and medicinal chemistry of CDK9 inhibitors: an update.\" Journal of medicinal chemistry 63.22 (2020): 13228-13257.", "url": "https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c00744", "doc_type": "JA", "public_domain": true }, { "uuid": "ecc26731-4e35-492d-b047-34fcd717ba13", "citation": "PUBCHEM", "doc_type": "PUBCHEM", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "c8465700-603b-49a1-acc2-4d72d0afcb2f", "citation": "STN (SCIFINDER)", "doc_type": "STN (SCIFINDER)", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "e8461712-e359-411a-8e63-6a3d0db43474", "citation": "Wu, Tizhi, et al. \"Recent developments in the biology and medicinal chemistry of CDK9 inhibitors: an update.\" Journal of medicinal chemistry 63.22 (2020): 13228-13257.", "url": "https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c00744", "doc_type": "JA", "public_domain": true }, { "uuid": "a57dfe9f-10c8-4718-b9c3-342e575b0ac5", "citation": "Cirstea, Diana, et al. \"Small-molecule multi-targeted kinase inhibitor RGB-286638 triggers P53-dependent and-independent anti-multiple myeloma activity through inhibition of transcriptional CDKs.\" Leukemia 27.12 (2013): 2366-2375.", "url": "https://www.nature.com/articles/leu2013194", "doc_type": "JA", "public_domain": true }, { "uuid": "6b4e15d6-5d67-4b10-b4ed-86e3559c9782", "citation": "Wu, Tizhi, et al. \"Recent developments in the biology and medicinal chemistry of CDK9 inhibitors: an update.\" Journal of medicinal chemistry 63.22 (2020): 13228-13257.", "url": "https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c00744", "doc_type": "JA", "public_domain": true }, { "uuid": "aaeaa4fe-52a2-4b22-b243-671e9126d53d", "citation": "Wu, Tizhi, et al. \"Recent developments in the biology and medicinal chemistry of CDK9 inhibitors: an update.\" Journal of medicinal chemistry 63.22 (2020): 13228-13257.", "url": "https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c00744", "doc_type": "JA", "public_domain": true }, { "uuid": "4e36d7d4-120c-4d5d-93f2-b7dda6c2c2ca", "citation": "Brasca, Maria Gabriella, et al. \"Optimization of 6, 6-dimethyl pyrrolo [3, 4-c] pyrazoles: Identification of PHA-793887, a potent CDK inhibitor suitable for intravenous dosing.\" Bioorganic & medicinal chemistry 18.5 (2010): 1844-1853.", "url": "https://pdf.sciencedirectassets.com/271397/1-s2.0-S0968089610X00050/1-s2.0-S0968089610000635/main.pdf?X-Amz-Security-Token=IQoJb3JpZ2luX2VjEMX%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLWVhc3QtMSJHMEUCIEjDdLASArdp%2FrwAMpxhEaqCrRMB8Zhy%2FRcDEBToghRbAiEAnOxdegaDIfDTQ2mkJkzX5wVZAZvX3X3qZAcsE7c51RkqswUIXhAFGgwwNTkwMDM1NDY4NjUiDOccbbNH79bkQvVXNiqQBSZ%2BZNT11yCSeARUCUY7LQ1avTe%2BaM8r898l9aUAlVRuCqKUJgaybiqvO7MBZud9YJH4250wJpRUgLSAI2y%2BFTP7p2MNwySSkJ3ggsxQ103da7wem%2BkfjYMsn0LpXV9k7dgzJXoU4%2FzlZkzG2KeBsd4eYYdQVPcxwhOb02syst3%2FNN5I%2Fb47Yv0J%2FkPDNGyAiYBFEFCruVye3rMO0d5YcLZcNZp3q4uxA4HeXQpQu5dI366k2LT%2BUk3KJvpp218V%2F2oNkZOvAqYyXym5q%2F1x0i%2FOoTZV0rQV7bodAdmLKjwKX3WKuEa4zfBjWHhQP7FYCuqRWnVdc%2F7lmqODsHi8ATim13ZlwPUeIAxrSGeyfY4VVx72ejGJbeKiDYrTYqBOXjKNVrJw%2F7BmrAQWqBSM%2B4p1KR7yeiPr6Rl8OcJHC4brc9YxYgX62vDyEUR0NZD1mOFTyZHrXdYIc8BM9pNZnPDd6HMyW2YXPqszPQnx71p3oU%2BpkHjAKjdxP8graGcjgrjr%2BFR4GtDHytsFq7Vx%2B9GZwYqYIcx%2FxmFNjpjrK1GMIND0s3eKliQ9E4RlPyGfLh6n2jFMCpaJgW1n9CBw2QkvZqSdP5m4AiTtRvE4DfAe0hvhy2rVgbnu4Rh9Oyoid4xlfjDypW4Yr5HEhfobGaGMh2iROC3DKRe1sPXqz4UJliDZbVRCoc0A07U5q33RllSlmF%2BXoIOJ%2BbtcaH91M8nSVJYNIOZbzZfwKLKzz1CFaDMOIjudy3cYsOg4b%2Fdxg2T01PyYh1do7CVot8LBXmdZIxShJBaGeeRq%2BS0tGz5zYe07QxD6ypJSqMfzYn0Yj%2Bnj8FemdjW5tRXrJgsF1pmLNUZSthcytrBzwi0vzyb7MKvUiaYGOrEBSZ%2F2Nm41yVC20S4JSPWOyPeUVlS%2FLLJeDDvwaP83ol6NLpLFXnm9N1FVb9svY2FvBj7CgC%2BTU05ujmGvmJcGEECWABWwHaWqaZ3PkzhA%2BPtZC86Nz8qcVfCx3fvdE7gu2SZtrIld8gmeBx17dFIss%2FKMLDqAou0xNn3B9kRryoRIIfmG6aCZjfRRPlbaYk%2BJ7ZLT7sEzkWuCpbkgA5WG9AFd2m9QOR4hYtuRYCJSW9bo&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Date=20230727T134307Z&X-Amz-SignedHeaders=host&X-Amz-Expires=300&X-Amz-Credential=ASIAQ3PHCVTYX7NZNWTX%2F20230727%2Fus-east-1%2Fs3%2Faws4_request&X-Amz-Signature=cc93569a801393e358bfe4505b731750d45a3a5ae2c5053d416d7e9a80bdfa82&hash=7e338a4e0a18acb46275fcb6ca278838117b3dbf6ce374e24466b766924cfa80&host=68042c943591013ac2b2430a89b270f6af2c76d8dfd086a07176afe7c76c2c61&pii=S0968089610000635&tid=spdf-85937832-fa6b-4db7-ba28-a5e294965adf&sid=c2ce39d564aec74b210b3f76f6ae311d60aagxrqa&type=client&tsoh=d3d3LnNjaWVuY2VkaXJlY3QuY29t&ua=0f1d580b0b53530756&rr=7ed54f3cfee20802&cc=us", "doc_type": "JA", "public_domain": true } ], "definition_type": "PRIMARY", "definition_level": "COMPLETE", "uuid": "df25bc97-cc4b-49bf-a583-17e90e65cc7b", "version": "37", "unii": "U3P2YH5TIJ", "relationships": [ { "uuid": "f426850f-7eaa-4c6f-ac43-088801844554", "amount": { "uuid": "dd511af4-f1f0-40c9-a1d7-e3801dd4afdb" }, "type": "INHIBITOR->TARGET", "interaction_type": "IN-VITRO", "related_substance": { "uuid": "b56a8b45-c4a6-470c-9836-0248671c0f22", "refuuid": "9b17f53c-4b0a-48d1-859d-57322b3bf08f", "name": "Istisociclib", "unii": "F7J6KSY5I8", "linking_id": "F7J6KSY5I8", "ref_pname": "Istisociclib" } }, { "uuid": "9e77409f-8ebf-4bca-9b2a-741f546a97fe", "amount": { "uuid": "99131e8f-45b8-4e97-860b-3f48dfc90e21", "average": 26, "units": "NANOMOLAR" }, "qualification": "IC50", "type": "INHIBITOR->TARGET", "references": [ "aaeaa4fe-52a2-4b22-b243-671e9126d53d" ], "related_substance": { "uuid": "7c0c49fb-da7a-4cb2-bcf7-de8a914ee7f4", "refuuid": "7e1dece3-272d-4602-a613-821083a94a03", "name": "FADRACICLIB", "unii": "YET2XNU791", "linking_id": "YET2XNU791", "ref_pname": "FADRACICLIB" } }, { "uuid": "8777e48a-9ccc-4a3e-b909-49f90260f3e0", "amount": { "uuid": "3ecfeb72-57ea-4520-bd9c-cce9d5c72f3d", "average": 3.3, "units": "NANOMOLAR" }, "qualification": "Kd", "type": "INHIBITOR->TARGET", "related_substance": { "uuid": "146ccb79-3602-49c7-a8b5-a812c8fc960b", "refuuid": "ba6b4012-13e5-4556-afbf-2dba2b07f01a", "name": "BTX-A51", "unii": "L46P54NB4V", "linking_id": "L46P54NB4V", "ref_pname": "BTX-A51" } }, { "uuid": "910eb69f-0ec9-4b4b-9adf-81cc6198f83e", "amount": { "uuid": "4cf5a787-e96a-4a92-a371-83c76e23cfe6", "high": 10 }, "qualification": "IC50", "type": "INHIBITOR->TARGET", "related_substance": { "uuid": "974096b0-f73d-425b-8368-bb3e45fd0dd6", "refuuid": "de94f442-2610-46b4-b81d-17ba348c1d30", "name": "AT-7519", "unii": "X1BF92PW9T", "linking_id": "X1BF92PW9T", "ref_pname": "AT-7519" } }, { "uuid": "09539a95-e8e8-46d9-a243-604e86df3282", "amount": { "uuid": "561d78fb-0e11-4439-b45f-d4985404d4a3", "average": 3, "units": "NANOMOLAR" }, "qualification": "IC50", "type": "INHIBITOR->TARGET", "references": [ "86f3eda4-4ed3-493f-948b-44f0d51763e5", "61c2588a-f47f-40b6-9956-5ff0ba0e75c9" ], "related_substance": { "uuid": "565983f8-d47e-412d-a472-da893484bf70", "refuuid": "ac53b26f-9cf5-49dd-92c5-a56692838bd5", "name": "Enitociclib", "unii": "1255AT22ZJ", "linking_id": "1255AT22ZJ", "ref_pname": "Enitociclib" } }, { "uuid": "105ff27e-58c3-49e4-8fd2-12225d31d822", "amount": { "uuid": "06ae81af-fcc0-45ae-8c63-a260c77b5298", "average": 6, "units": "NANOMOLAR" }, "qualification": "IC50", "type": "INHIBITOR->TARGET", "references": [ "ecc26731-4e35-492d-b047-34fcd717ba13", "c8465700-603b-49a1-acc2-4d72d0afcb2f", "e8461712-e359-411a-8e63-6a3d0db43474" ], "related_substance": { "uuid": "3ee9c69f-299c-44dc-8a3e-5ae05c14bc11", "refuuid": "3bafa063-761a-4215-a478-63a0383f8453", "name": "ATUVECICLIB", "unii": "63Q7F59W0V", "linking_id": "63Q7F59W0V", "ref_pname": "ATUVECICLIB" } }, { "uuid": "bde1651a-6bf6-4773-9e4b-e8d8d462d7f3", "amount": { "uuid": "cba35551-fadb-45dc-bbbc-30d57fcd0d88", "average": 3, "units": "NANOMOLAR" }, "qualification": "IC50", "type": "INHIBITOR->TARGET", "references": [ "59f73705-5c4c-4b68-9b3c-bf0735c6a97e" ], "related_substance": { "uuid": "9bb41de8-4c7a-4732-8e76-4c0b5ed349c2", "refuuid": "a1fbead3-560e-403e-801a-4f8049b66e66", "name": "ALVOCIDIB", "unii": "45AD6X575G", "linking_id": "45AD6X575G", "ref_pname": "ALVOCIDIB" } }, { "uuid": "d7dce125-4820-4a4e-bff2-3fefcd674a3c", "amount": { "uuid": "09946e60-f67e-4f5a-88bd-3161c9d58a28", "average": 0.626, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "INHIBITOR->TARGET", "references": [ "0c5bc5bd-e3ea-4567-bd30-86e0cd5d3ee3" ], "related_substance": { "uuid": "edd93c1e-6666-4edb-8528-c2b0b8c3f9a4", "refuuid": "204e9294-2380-41b3-b3d2-3c30ece35d3c", "name": "VORUCICLIB", "unii": "W66XP666AM", "linking_id": "W66XP666AM", "ref_pname": "VORUCICLIB" } }, { "uuid": "84163f46-1394-4a79-a00b-f54f14eafa87", "amount": { "uuid": "cdbe86ba-a7d8-4ba4-9d24-04983d7c1bcd", "high": 4, "low": 1, "units": "NANOMOLAR" }, "qualification": "IC50", "type": "INHIBITOR->TARGET", "references": [ "3de68a42-bfd6-4e7b-a63f-ba616da3d307" ], "related_substance": { "uuid": "8bab0514-b825-49e7-b899-220c2e1ef633", "refuuid": "0ffab2e2-8e9b-4c5d-8368-1b3730c03184", "name": "DINACICLIB", "unii": "4V8ECV0NBQ", "linking_id": "4V8ECV0NBQ", "ref_pname": "DINACICLIB", "substance_class": "reference" } }, { "uuid": "e6467cf1-c016-4dd0-b0b4-4aa359628ad0", "amount": { "uuid": "dcc6ee18-65fb-4086-aa5b-82e9cf71b632", "average": 50, "units": "NANOMOLAR" }, "type": "INHIBITOR->TARGET", "references": [ "84fdca82-f3be-494c-94ab-c19b28d30bf0" ], "related_substance": { "uuid": "0d965768-bddd-4f8b-9d95-67004982c795", "refuuid": "e5dd47ae-f848-412c-846d-8762dea6bdbb", "name": "Trilaciclib", "unii": "U6072DO9XG", "linking_id": "U6072DO9XG", "ref_pname": "Trilaciclib" } }, { "uuid": "9499d544-e465-44e0-b5f8-f44f034c0a6d", "amount": { "uuid": "8f35d89c-92b4-4114-883a-53c38ba3f393", "average": 4, "units": "NANOMOLAR" }, "qualification": "IC50", "type": "INHIBITOR->TARGET", "references": [ "a853084b-5fbe-4c68-a22e-0e1cd50be6ed" ], "related_substance": { "uuid": "fa4aee43-8b0a-40f4-a6de-78c3b5421192", "refuuid": "7b61d56b-bc19-4bad-a65b-577e50e44545", "name": "SNS-032", "unii": "9979I93686", "linking_id": "9979I93686", "ref_pname": "SNS-032", "substance_class": "reference" } }, { "uuid": "e9ee53b7-0f75-4456-8a7f-8d28d46c9560", "amount": { "uuid": "00fb50c4-9004-4b15-bd06-fb08ed3e420b", "average": 28, "units": "NANOMOLAR" }, "type": "INHIBITOR->TARGET", "related_substance": { "uuid": "1ebb5417-50a4-45e4-9298-6535004e620d", "refuuid": "99113be8-c15d-448e-9c2d-57af27a65942", "name": "LEROCICLIB", "unii": "WBH8AY6ENB", "linking_id": "WBH8AY6ENB", "ref_pname": "LEROCICLIB" } }, { "uuid": "d520ec04-8af5-437b-82c3-95f00ea9134b", "amount": { "uuid": "57452f31-cff3-4fe4-9c27-4e1829daaddb", "average": 138, "units": "NANOMOLAR" }, "type": "INHIBITOR->TARGET", "mediator_substance": { "uuid": "4e02464f-ed40-4590-8b32-41d92543162f", "refuuid": "b92ca8e5-a4cd-44a1-aaac-3606a564b990", "name": "Cyclin T1", "unii": "AW6D4279ZA", "linking_id": "AW6D4279ZA", "ref_pname": "Cyclin T1", "substance_class": "reference" }, "references": [ "4e36d7d4-120c-4d5d-93f2-b7dda6c2c2ca" ], "related_substance": { "uuid": "06edce97-9c92-4438-b24b-d145afb438fd", "refuuid": "d144061e-e5ad-4240-bd5a-2679d50d046b", "name": "PHA-793887", "unii": "MKS45S912B", "linking_id": "MKS45S912B", "ref_pname": "PHA-793887", "substance_class": "reference" } }, { "uuid": "ab13d42f-f6bc-4a33-9b6a-2775135fc650", "amount": { "uuid": "f28d5900-cb45-4720-8f3e-5e1b3739bd89", "average": 20, "units": "NANOMOLAR" }, "qualification": "IC50", "type": "INHIBITOR->TARGET", "references": [ "1175a8ef-a7cf-4330-b51a-37b9b3e4f411" ], "related_substance": { "uuid": "50889e77-1879-41da-90b6-3091570c31a7", "refuuid": "4da1ee7b-a3fd-4a27-8298-978d347d0d5d", "name": "AZD-5438", "unii": "276Z913G29", "linking_id": "276Z913G29", "ref_pname": "AZD-5438", "substance_class": "reference" } }, { "uuid": "14818374-e3f7-4464-b979-11476b747a28", "amount": { "uuid": "3a5b7341-82d6-4805-bc1a-30ab6b717dfd", "average": 1, "units": "NANOMOLAR" }, "qualification": "IC50", "type": "INHIBITOR->TARGET", "mediator_substance": { "uuid": "229023b3-6962-4350-b257-0c4d3efa318a", "refuuid": "b92ca8e5-a4cd-44a1-aaac-3606a564b990", "name": "Cyclin T1", "unii": "AW6D4279ZA", "linking_id": "AW6D4279ZA", "ref_pname": "Cyclin T1", "substance_class": "reference" }, "references": [ "a57dfe9f-10c8-4718-b9c3-342e575b0ac5" ], "related_substance": { "uuid": "ea623b8b-8f6f-477f-a972-84de6c1f7f34", "refuuid": "7bcb0b97-062a-4f9c-871f-b4144da2b9c4", "name": "RGB-286638 FREE BASE", "unii": "1GAJ98SC2X", "linking_id": "1GAJ98SC2X", "ref_pname": "RGB-286638 FREE BASE", "substance_class": "reference" } }, { "uuid": "e87a5677-2f8c-420f-b8d2-d82f50cfdcf3", "amount": { "uuid": "8d479ecb-2d78-461c-ba8b-bc154a714cea", "average": 20, "units": "NANOMOLAR" }, "qualification": "IC50", "type": "INHIBITOR->TARGET", "references": [ "af1237a0-1e18-481b-844f-833b0720e2e4" ], "related_substance": { "uuid": "4f71e643-4d47-48ed-93f4-53319aecf285", "refuuid": "b5c727ef-d25f-4d80-929b-b15c09c94eeb", "name": "RIVICICLIB", "unii": "9EK26WE8QN", "linking_id": "9EK26WE8QN", "ref_pname": "RIVICICLIB", "substance_class": "reference" } }, { "uuid": "57e6cad8-fd36-4dc5-8168-77e3e9e34729", "amount": { "uuid": "9c6f70b9-4e02-436d-ae0d-1560ceae0a95", "average": 5, "units": "NANOMOLAR" }, "qualification": "IC50", "type": "INHIBITOR->TARGET", "related_substance": { "uuid": "01a51073-e603-4246-bb53-517be5f519bd", "refuuid": "7451d11f-303a-4eeb-897a-1e8518ee4760", "name": "ZK-304709", "unii": "29713BMI56", "linking_id": "29713BMI56", "ref_pname": "ZK-304709", "substance_class": "reference" } }, { "uuid": "58671b9b-1ace-4b38-bbf9-1baa595d98bf", "amount": { "uuid": "c35b201b-ed15-40b9-b133-20e651db1081", "average": 5, "units": "NANOMOLAR" }, "qualification": "IC50", "type": "INHIBITOR->TARGET", "references": [ "52b5094d-4454-4af6-9021-d7a9f2f35ff6" ], "related_substance": { "uuid": "8fa3286d-e41d-4082-b98c-88bfe787ba27", "refuuid": "cbe99f1c-39fe-427e-87c7-35ac9213faa6", "name": "RONICICLIB", "unii": "0W9Q8U337A", "linking_id": "0W9Q8U337A", "ref_pname": "RONICICLIB", "substance_class": "reference" } }, { "uuid": "6cda7763-ecf6-462b-9d09-49ed19a51a8d", "amount": { "uuid": "3ce14e29-f4ba-4fc0-bcb6-15a62b382b78", "average": 3, "units": "NANOMOLAR" }, "qualification": "IC50", "type": "INHIBITOR->TARGET", "references": [ "5385ee69-f75a-4c9c-9537-baa9a6a64d6f" ], "related_substance": { "uuid": "8989ad3a-3e2b-43be-9543-32eda16ce2e9", "refuuid": "8a039abd-49b8-4d52-846d-6554fe17039c", "name": "ZOTIRACICLIB", "unii": "40D08182TT", "linking_id": "40D08182TT", "ref_pname": "ZOTIRACICLIB", "substance_class": "reference" } }, { "uuid": "97b9301d-c2f1-471d-8f18-b2e72f06ac22", "amount": { "uuid": "2fc9d7a1-bd53-4f18-bb63-91ced3cf2888", "average": 230, "units": "NANOMOLAR" }, "qualification": "IC50", "type": "INHIBITOR->TARGET", "references": [ "6b4e15d6-5d67-4b10-b4ed-86e3559c9782" ], "related_substance": { "uuid": "dc034229-3c5c-4224-94c2-7220c632de63", "refuuid": "859ca1d4-3a3c-4c79-8944-875806677af7", "name": "SELICICLIB", "unii": "0ES1C2KQ94", "linking_id": "0ES1C2KQ94", "ref_pname": "SELICICLIB", "substance_class": "reference" } } ], "names": [ { "uuid": "e0608e88-4b7b-46fe-a0b3-81d565984c27", "name": "C-2K", "stdName": "C-2K", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "497f6f00-e9ba-4c4c-8611-1979f62a3d09", "4adbba03-0001-4945-b401-a47431a5eac8" ], "display_name": false }, { "uuid": "2e78d0b0-9c6c-442c-b282-46dd776cae66", "name": "CDC2L4", "stdName": "CDC2L4", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "497f6f00-e9ba-4c4c-8611-1979f62a3d09", "4adbba03-0001-4945-b401-a47431a5eac8" ], "display_name": false }, { "uuid": "499fc3dd-96d3-ccc2-ca7e-7c8ad1a7b070", "name": "CDK9", "stdName": "CDK9", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "e601a253-ef8b-14f7-1f43-2e22bfc70c0e" ], "display_name": false }, { "uuid": "b705fcc1-68e6-41cc-912a-f98a299fbc72", "name": "CELL DIVISION CYCLE 2-LIKE PROTEIN KINASE 4", "stdName": "CELL DIVISION CYCLE 2-LIKE PROTEIN KINASE 4", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "497f6f00-e9ba-4c4c-8611-1979f62a3d09", "4adbba03-0001-4945-b401-a47431a5eac8" ], "display_name": false }, { "uuid": "fa14ea9a-7909-4336-9bd8-250d4dee37b8", "name": "CELL DIVISION PROTEIN KINASE 9", "stdName": "CELL DIVISION PROTEIN KINASE 9", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "497f6f00-e9ba-4c4c-8611-1979f62a3d09", "904119e2-29cf-4331-9d3d-568472cf103b" ], "display_name": false }, { "uuid": "cec3a301-a873-4347-a5bf-5d65874325c6", "name": "CYCLIN-DEPENDENT KINASE 9", "stdName": "CYCLIN-DEPENDENT KINASE 9", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "497f6f00-e9ba-4c4c-8611-1979f62a3d09", "4adbba03-0001-4945-b401-a47431a5eac8" ], "display_name": true }, { "uuid": "a9097176-9004-4948-bca5-20feb8db733d", "name": "SERINE/THREONINE-PROTEIN KINASE PITALRE", "stdName": "SERINE/THREONINE-PROTEIN KINASE PITALRE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "497f6f00-e9ba-4c4c-8611-1979f62a3d09", "904119e2-29cf-4331-9d3d-568472cf103b" ], "display_name": false }, { "uuid": "923d425c-b3ab-45e5-81dc-cba259dd0762", "name": "TAK", "stdName": "TAK", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "497f6f00-e9ba-4c4c-8611-1979f62a3d09", "4adbba03-0001-4945-b401-a47431a5eac8" ], "display_name": false }, { "uuid": "fd3a12f7-7d29-4fee-8c44-d1c7884e5df2", "name": "TAT-ASSOCIATED KINASE COMPLEX CATALYTIC SUBUNIT", "stdName": "TAT-ASSOCIATED KINASE COMPLEX CATALYTIC SUBUNIT", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "497f6f00-e9ba-4c4c-8611-1979f62a3d09", "904119e2-29cf-4331-9d3d-568472cf103b" ], "display_name": false } ], "protein": { "uuid": "e529ca76-54c4-4d7c-9b27-0bf9be38e481", "glycosylation": { "uuid": "974487ab-40ba-4b9d-a3be-cc44c485d002" }, "subunits": [ { "uuid": "eaadbd22-7a56-4ba3-b080-b61c6bdb8775", "sequence": "MAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRKGSQITQQSTNQSRNPATTNQTEFERVF", "subunit_index": 1 } ], "references": [ "4adbba03-0001-4945-b401-a47431a5eac8" ], "protein_sub_type": "", "sequence_type": "COMPLETE" }, "properties": [ { "uuid": "e976dfb4-59d7-47a0-8e69-674348893398", "name": "MOL_WEIGHT", "type": "amount", "value": { "uuid": "ecf945a5-5aa0-4b65-b45f-62b4a755ed9a", "units": "DA" }, "defining": false, "property_type": "CHEMICAL" }, { "uuid": "a1fbf357-4a55-4dba-992b-eeaf4b3df46d", "name": "Molecular Formula", "value": { "uuid": "ea592f24-5715-4305-a621-726bf7cd2c6d", "type": "ESTIMATED", "non_numeric_value": "C1916H3047N526O575P7S18" }, "defining": false, "property_type": "CHEMICAL" } ], "modifications": { "uuid": "6b8386fb-2d64-41f6-97ac-86129589efd6", "structural_modifications": [ { "uuid": "7ba07de9-6c74-42c5-aca6-e759661b5982", "extent": "COMPLETE", "sites": [ { "residue_index": 175, "subunit_index": 1 }, { "residue_index": 353, "subunit_index": 1 }, { "residue_index": 357, "subunit_index": 1 } ], "location_type": "SITE_SPECIFIC", "molecular_fragment": { "uuid": "6136fc3d-fd10-4ef8-a1ad-cdaf4cf662d3", "refuuid": "b6eb2edb-1b4d-46ad-92ad-a43f0f545926", "name": "DEXFOSFOSERINE", "unii": "VI4F0K069V", "linking_id": "VI4F0K069V", "ref_pname": "DEXFOSFOSERINE", "substance_class": "reference" }, "residue_modified": "S", "structural_modification_type": "AMINO_ACID_SUBSTITUTION" }, { "uuid": "90f17a78-d221-4bf9-b920-12b766d0f8bc", "extent": "COMPLETE", "sites": [ { "residue_index": 350, "subunit_index": 1 }, { "residue_index": 354, "subunit_index": 1 }, { "residue_index": 362, "subunit_index": 1 }, { "residue_index": 363, "subunit_index": 1 } ], "location_type": "SITE_SPECIFIC", "molecular_fragment": { "uuid": "89543249-5399-42cc-9fe1-ede204308420", "refuuid": "96bbf36a-d049-4313-9712-8608530faef7", "name": "THREONINE PHOSPHATE", "unii": "3L4WX7B1EI", "linking_id": "3L4WX7B1EI", "ref_pname": "THREONINE PHOSPHATE", "substance_class": "reference" }, "residue_modified": "T", "structural_modification_type": "AMINO_ACID_SUBSTITUTION" } ] } } ] }